To the best of our knowledge, this is the first study that elucidates the essential role of endothelial AMPKα1 in hyperoxia-mediated experimental BPD-PH, and emphasizes that AMPKα1 is a potential therapeutic target for BPD infants who develop PH. This evidence concerns the gene PRKAA1 and bronchopulmonary dysplasia.